ELUT
Elutia Inc - Ordinary Shares - Class A

662
Mkt Cap
$28.14M
Volume
74,193.00
52W High
$5.12
52W Low
$0.6588
PE Ratio
-0.72
ELUT Fundamentals
Price
$0.64
Prev Close
$0.659
Open
$0.655
50D MA
$0.9316
Beta
0.35
Avg. Volume
303,095.35
EPS (Annual)
-$1.86
P/B
-0.64
Rev/Employee
$477,941.18
Loading...
Loading...
News
all
press releases
David Colpman Buys 15,500 Shares of Elutia (NASDAQ:ELUT) Stock
Elutia Inc. (NASDAQ:ELUT - Get Free Report) Director David Colpman purchased 15,500 shares of the firm's stock in a transaction dated Monday, November 17th. The shares were purchased at an average...
MarketBeat·3h ago
News Placeholder
More News
News Placeholder
Elutia (NASDAQ:ELUT) CEO Buys $10,125.00 in Stock
Elutia Inc. (NASDAQ:ELUT - Get Free Report) CEO C Randal Mills acquired 13,500 shares of the firm's stock in a transaction on Thursday, November 13th. The stock was bought at an average price of...
MarketBeat·5d ago
News Placeholder
Down 25.9% in 4 Weeks, Here's Why ELUTIA INC (ELUT) Looks Ripe for a Turnaround
ELUTIA INC (ELUT) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Zacks·2mo ago
News Placeholder
All You Need to Know About ELUTIA INC (ELUT) Rating Upgrade to Buy
ELUTIA INC (ELUT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks·3mo ago
News Placeholder
Contrasting Elutia (NASDAQ:ELUT) & CG Oncology (NASDAQ:CGON)
Elutia (NASDAQ:ELUT Get Free Report) and CG Oncology (NASDAQ:CGON Get Free Report) are both medical companies, but which is the superior stock? We will compare the two businesses...
Zolmax·2y ago
News Placeholder
Head to Head Survey: Elutia (NASDAQ:ELUT) vs. Pluri (NASDAQ:PLUR)
Elutia (NASDAQ:ELUT Get Free Report) and Pluri (NASDAQ:PLUR Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two...
Zolmax·2y ago
News Placeholder
Elutia Reports Fourth Quarter and Full Year 2023 Financial Results: Anticipates CanGarooRM Clearance Decision in First Half of 2024
SILVER SPRING, Md., March 07, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) ( Elutia or the Company ) today provided a business update and reported financial results for the fourth quarter...
Globe Newswire·2y ago
News Placeholder
Elutia to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 7, 2024
SILVER SPRING, Md., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) ( Elutia ), a company pioneering drug-eluting biomatrix products, today announced that it will release its fourth...
Globe Newswire·2y ago
News Placeholder
Elutia Inc.'s (NASDAQ:ELUT) Share Price Is Matching Sentiment Around Its Revenues
You may think that with a price-to-sales (or "P/S") ratio of 1.5x Elutia Inc. ( NASDAQ:ELUT ) is definitely a stock...
Simply Wall St·2y ago
News Placeholder
Elutia management to meet with Lake Street
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly·2y ago

Latest ELUT News

View

Advertisement|Remove ads.

Advertisement|Remove ads.